207 related articles for article (PubMed ID: 29578462)
1. Preparation and in vitro-in vivo characterization of trans-resveratrol nanosuspensions.
Dong Q; Yuan HL; Qian JJ; Zhang CY; Chen WD
Biomed Mater Eng; 2018; 29(3):333-345. PubMed ID: 29578462
[TBL] [Abstract][Full Text] [Related]
2. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration.
Singh SK; Makadia V; Sharma S; Rashid M; Shahi S; Mishra PR; Wahajuddin M; Gayen JR
Drug Deliv Transl Res; 2017 Jun; 7(3):395-407. PubMed ID: 28194730
[TBL] [Abstract][Full Text] [Related]
4. Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies.
Singh G; Pai RS
Drug Deliv; 2015; 22(4):522-30. PubMed ID: 24512464
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles.
Zu Y; Zhang Y; Wang W; Zhao X; Han X; Wang K; Ge Y
Drug Deliv; 2016; 23(3):981-91. PubMed ID: 24918466
[TBL] [Abstract][Full Text] [Related]
6. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
Siu FY; Ye S; Lin H; Li S
Int J Nanomedicine; 2018; 13():4133-4144. PubMed ID: 30038494
[TBL] [Abstract][Full Text] [Related]
7. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
8. Development of a Solid Dispersion System for Improving the Oral Bioavailability of Resveratrol in Rats.
Chang CW; Wong CY; Wu YT; Hsu MC
Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):239-249. PubMed ID: 27118361
[TBL] [Abstract][Full Text] [Related]
9. Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol.
Balata GF; Essa EA; Shamardl HA; Zaidan SH; Abourehab MA
Drug Des Devel Ther; 2016; 10():117-28. PubMed ID: 26792979
[TBL] [Abstract][Full Text] [Related]
10. Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate.
Qiao H; Chen L; Rui T; Wang J; Chen T; Fu T; Li J; Di L
Int J Nanomedicine; 2017; 12():1033-1046. PubMed ID: 28223797
[TBL] [Abstract][Full Text] [Related]
11. Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability.
Shen G; Cheng L; Wang LQ; Zhang LH; Shen BD; Liao WB; Li JJ; Zheng J; Xu R; Yuan HL
Chin J Nat Med; 2016 Oct; 14(10):757-768. PubMed ID: 28236405
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of targeting tumor with folate-based amphiphilic multifunctional stabilizer for resveratrol nanosuspensions.
Wang L; Liu Y; Zhao J; Li C; Zhou Y; Du J; Wang Y
Colloids Surf B Biointerfaces; 2017 Dec; 160():462-472. PubMed ID: 28988124
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in-vitro/in-vivo evaluation of curcumin nanosuspension with solubility enhancement.
Li X; Yuan H; Zhang C; Chen W; Cheng W; Chen X; Ye X
J Pharm Pharmacol; 2016 Aug; 68(8):980-8. PubMed ID: 27283220
[TBL] [Abstract][Full Text] [Related]
14. Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design.
Hao J; Gao Y; Zhao J; Zhang J; Li Q; Zhao Z; Liu J
AAPS PharmSciTech; 2015 Feb; 16(1):118-28. PubMed ID: 25209687
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
16. Improved stability and oral bioavailability of Ganneng dropping pills following transforming lignans of herpetospermum caudigerum into nanosuspensions.
Li JJ; Cheng L; Shen G; Qiu L; Shen CY; Zheng J; Xu R; Yuan HL
Chin J Nat Med; 2018 Jan; 16(1):70-80. PubMed ID: 29425592
[TBL] [Abstract][Full Text] [Related]
17. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol nanosuspensions for dermal application--production, characterization, and physical stability.
Kobierski S; Ofori-Kwakye K; Müller RH; Keck CM
Pharmazie; 2009 Nov; 64(11):741-7. PubMed ID: 20099519
[TBL] [Abstract][Full Text] [Related]
19. [Study on preparation and characterization of resveratrol solid lipid nanoparticles and its anticancer effects in vitro].
Zhang QH; Xiong QP; Shi YY; Zhang DY
Zhong Yao Cai; 2010 Dec; 33(12):1929-32. PubMed ID: 21548373
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
Wang Y; Han X; Wang J; Wang Y
Int J Pharm; 2016 May; 505(1-2):35-41. PubMed ID: 27034003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
